Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats

被引:7
|
作者
Ikehara, O
Nishimura, H
Naito, T
Higuchi, C
Sanaka, T
机构
[1] Shimizu Pharmaceut Co Ltd, CAPD Div, Dept Res & Dev, Shizuoka, Japan
[2] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Tokyo, Japan
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2005年 / 100卷 / 01期
关键词
biocompatibility of PD treatment; glucose degradation products; imprint; peritoneal dialysis solution; peritoneal membrane; pH;
D O I
10.1159/000084110
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In vitro studies have shown that pH and glucose degradation products (GDPs) in the dialysate are determinant factors for the biocompatibility of peritoneal dialysis (PD) treatment. The present study was thus designed to evaluate whether a newly developed PD solution, which features neutral pH levels and a low GDP concentration, influences tissue damage of the peritoneal membrane in an in vivo setting, and which factor is more critical to the histological changes. Methods: Rats were injected 3 times per day during 1 or 4 weeks with 10 ml of various PD fluids ( group G, acidic pH, high GDPs; group S, neutral pH, low GDPs; or group A, acidic pH, low GDPs). When the experimental period was over, the mesothelial cell monolayers of the animals were taken and studied with population analysis, and peritoneal membranes were obtained from the abdominal wall for immunohistochemical examination with proliferating cell nuclear antigen ( PCNA) and for measurement of thickness of the peritoneal specimens. Results: The density of the mesothelial cell monolayer and the number of fibroblast-like cells in group S were significantly less than in group G at 1 and 4 weeks' injection. PCNA-positive nuclei in group S were significantly less than in group G for only the 1-week injection set ( group G, 2.03 +/- 0.95; group S, 0.85 +/- 1.18 nuclei/ 1 x 10(4) mu m(2)). At 4 weeks, the peritoneal thickness of group S (6.32 +/- 0.53 mu m) was significantly less than that of group G (7.94 +/- 0.77 mu m), There was no significant difference between groups S and A throughout the whole study period except for the result of the number of fibroblast-like cells. Conclusion: These results indicate that a PD solution with a neutral pH and low GDPs proved more biocompatible with the peritoneal membrane than a solution with an acidic pH and high GDPs. Furthermore, the level of the GDPs has more impact on tissue damage of the peritoneal membrane than the pH in the short term. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:E30 / E39
页数:10
相关论文
共 50 条
  • [31] Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - A 1-year randomized control trial
    Szeto, Cheuk-Chun
    Chow, Kai-Ming
    Lam, Christopher Wai-Kei
    Leung, Chi-Bon
    Kwan, Bonnie Ching-Ha
    Chung, Kwok-Yi
    Law, Man-Ching
    Li, Philip Kam-Tao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) : 552 - 559
  • [32] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products (vol 13, pg 480, 2002)
    Mortier
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1419 - 1421
  • [33] The protective effects of melatonin on peritoneal fibrosis induced by high glucose peritoneal dialysis in rats
    Wang, Xue-Rong
    Qi, Xiang-Ming
    Zhu, Qi-Jin
    Wu, Yong-Gui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 4764 - 4772
  • [34] A PERITONEAL DIALYSIS REGIMEN LOW IN GLUCOSE AND GLUCOSE DEGRADATION PRODUCTS RESULTS IN INCREASED CANCER ANTIGEN 125 AND PERITONEAL ACTIVATION
    le Poole, Caatje Y.
    Welten, Angelique G. A.
    ter Wee, Piet M.
    Paauw, Nanne J.
    Djorai, Amina N.
    Valentijn, Rob M.
    Beelen, Robert H. J.
    van den Born, Jacob
    van Ittersum, Frans J.
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (03): : 305 - 315
  • [35] Effects of a New Bicarbonate/Lactate-buffered Neutral Peritoneal Dialysis Fluid for Peritoneal Failure in Patients Undergoing Peritoneal Dialysis
    Hoshino, Taro
    Ishii, Hiroki
    Kitano, Taisuke
    Shindo, Mitsutoshi
    Miyazawa, Haruhisa
    Yamada, Hodaka
    Ito, Kiyonori
    Ueda, Yuichiro
    Kaku, Yoshio
    Hirai, Keiji
    Mori, Honami
    Ookawara, Susumu
    Tabei, Kaoru
    Morishita, Yoshiyuki
    DISCOVERY MEDICINE, 2016, 21 (114) : 81 - 88
  • [36] STABILITY OF THE COMBINATION OF CEFTAZIDIME AND CEPHAZOLIN IN ICODEXTRIN OR PH NEUTRAL PERITONEAL DIALYSIS SOLUTION
    Patel, Rahul P.
    Shastri, Madhur D.
    Bakkari, Mohammad
    Wanandy, Troy
    Jose, Matthew D.
    PERITONEAL DIALYSIS INTERNATIONAL, 2014, 34 (02): : 212 - 218
  • [37] Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane
    Mortier, S
    Faict, D
    Gericke, M
    Lameire, N
    De Vriese, A
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 101 (04): : E139 - E145
  • [38] Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
    Rippe, B
    Simonsen, O
    Heimbürger, O
    Christensson, A
    Haraldsson, B
    Stelin, G
    Weiss, L
    Nielsen, FD
    Bro, S
    Friedberg, M
    Wieslander, A
    KIDNEY INTERNATIONAL, 2001, 59 (01) : 348 - 357
  • [39] Reduction of peritoneal membrane permeability by long-term use of neutral-pH peritoneal dialysis solution: a preliminary report in high transporters
    Satoru Kuriyama
    Yasushi Otsuka
    Rinako Iida
    Seiji Kobayashi
    Hiroko Yamagishi
    Tatsuo Hosoya
    Journal of Clinical and Experimental Nephrology, 2004, 8 (4): : 392 - 393
  • [40] Effects of Low-glucose Degradation Product Solution on Peritoneal Membrane Characteristics in Peritoneal Dialysis Patients A 3-year Follow-up Study
    Park, Jong Won
    Kang, Seok Hui
    Do, Jun Young
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2014, 8 (01) : 58 - 64